Navigation Links
Aegera Initiates Phase 2 Clinical Trial Of AEG33773 - A Small Molecule Targeting Neuropathic Pain
Date:5/6/2009

>)

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics for major unmet medical needs. Aegera has three programs in clinical development. In addition to AEG33773, Aegera is developing

    - AEG35156 targets the key anti-apoptotic protein XIAP, and is in
      multiple randomized Phase II clinical trials;
    - HGS1029(AEG40826) is a small molecule pan-IAP inhibitor in Phase 1
      development. It has demonstrated very promising preclinical activity
      and is partnered with Human Genome Sciences, Inc. (Nasdaq:  HGSI) for o
      ncology in all countries except Japan.

'/>"/>
SOURCE AEGERA THERAPEUTICS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs
2. Aegera initiates Phase 1 clinical trial of AEG33773 - A small molecule in development for diabetic neuropathic pain
3. Aegera Therapeutics welcomes two experienced executives to its board of directors
4. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
5. Aegera Therapeutics phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting
6. Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
7. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
8. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
9. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
10. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
11. Nventa Initiates HspE7 Phase 1 Cervical Dysplasia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Mass. , Dec. 17, 2014   Synageva ... biopharmaceutical company developing therapeutic products for rare disorders, announced ... Conference being held in San Francisco, CA. ... President and Chief Executive Officer, will present on Monday, ... EST).  The presentation will be webcast live and may ...
(Date:12/15/2014)... , Dec. 15, 2014  GlassesOff Inc. (OTCBB: ... Bar-Gil as an independent director of the Company,s ... of AeroScout and served as its CEO until its ... 2012, a $240 million transaction. Recognized as the inventor ... Bar-Gil,s leadership, AeroScout provided Wi-Fi -based RFID solutions focused ...
(Date:12/13/2014)... TORONTO , Dec. 12, 2014 /CNW/ - MaRS and ... announced today that they have joined forces to support Canadian ... Branson , Virgin Group Founder was at the MaRS Centre ... a new, national impact venture fund. This fund has $1 ... the Vancouver -based Mindset Social Innovation Foundation, ...
(Date:12/13/2014)... The “Global Synthetic Biology Market (2013-2018)”, analyses ... and challenges. , The global synthetic biology market ... Fisher Scientific, Inc. (U.S.), DuPont (U.S.), and Royal ... approximately ~65% of the total synthetic biology market. ... Report @ http://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html , Thermo Fisher ...
Breaking Biology Technology:AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 2Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 3
... CHICAGO Being part of the more than 18,000 people ... biotech has not only become a worldwide phenomenon but its also ... of how rock n roll became mainstream in the 1960s. Though ... Beatles on the Sunday night Ed Sullivan Show was a statement ...
... become a better husband or wife, daughter or son, sister ... e-mail into a confessional. I've just been thinking about the ... making that relationship work, it's funny how frequently the conversation ... idealized family. , ,"Oh great!" you're thinking. "Now you want ...
... Ludwig Institute for Cancer Research , using technology made by ... identify thousands of regulatory sequences in the human genome, according ... of the study was to find within the human genome ... the genes that determine how cells in the body as ...
Cached Biology Technology:Biotech phenomenon becoming mainstream in world economy 2Biotech phenomenon becoming mainstream in world economy 3Biotech phenomenon becoming mainstream in world economy 4Biotech phenomenon becoming mainstream in world economy 5Taking your work home 2Taking your work home 3NimbleGen identifies human genome sequences 2
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center ... for its School of Medicine. Funding for this $50 ... campaign that will be publicly launched next summer. ... in the former 60 series R.J. Reynolds Tobacco Company ... Construction will begin immediately with plans to be ready ...
(Date:12/10/2014)... , Dec. 08, 2014 Research and ... the addition of the "Biometrics Market in ... http://photos.prnewswire.com/prnh/20130307/600769 ... projects such as rural banking and upgradation of ... trends witnessed in the market. Besides the aforementioned ...
(Date:12/5/2014)... MOUNTAIN VIEW, Calif. , Dec. 4, 2014 ... and safety has boosted investments in new testing ... products has also given rise to a range ... driven by the requirements of Generation Y, which ... digital technologies. As a result, product development strategies ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... have shown that using mud from waste water treatment plants ... reduce their CO 2 emissions and comply with the ... health and being profitable. These are the results of an ... and coal could be coming to an end. Researchers from ...
... way our brain handles how we move through spaceincluding ... shoesmay be related to how and why we experience ... in the online scientific journal PLoS ONE . ... Empathy involves, in part, the ability to simulate ...
... groundbreaking study conducted by Children,s Hospital & Research Center ... for harvesting stem cells from a woman,s placenta, or ... study also finds there are far more stem cells ... can be safely extracted for transplantation. Furthermore, it is ...
Cached Biology News:Waste water treatment plant mud used as 'green' fuel 2Ability to literally imagine oneself in another's shoes may be tied to empathy 2Ability to literally imagine oneself in another's shoes may be tied to empathy 3Children's Hospital Oakland scientists first to discover new source for harvesting stem cells 2
...
BD Falcon microtest assay plate. 1536 well 12l, black, flat-bottom PS. Polystyrene, nonsterile, no lid. (15/sp, 60/ca) Packaging: 15 / pack, 60 / case ...
... have low background fluorescence, minimal light ... (or medium binding) polystyrene surface is ... through passive interactions,• Is suitable ... molecules, such as antibodies, that have ...
... immunowash microplate washer, 100-240 V, is used ... U-, or V-bottom wells. This washer has ... to an accuracy of 0.1 mm for ... It can store up to 75 wash ...
Biology Products: